Pitchbook survey: VCs see AI as high growth but also overinvested
The biggest focus areas for AI investing are healthcare and biotech
Read more...Irvine, Calif-based BlueCava recently raised $9.5 million in Series B funding to build out its tracking technology that gives companies visibility into the consumers that visit their websites or view their advertisements online. The technology, which essentially tags devices based on browser information, can also be used by companies to identify fraudsters. BlueCava CEO and founder David Norris spoke with Bambi Francisco about how the tracking technology gets on devices, how consumers can protect their privacy from these devices, and how companies are currently using the technology. Norris also talks about how companies pay BlueCava. Currently, BlueCava customers pay per transaction (or when a device is tagged) for one or two-year plans.
Founder and CEO of Vator, a media and research firm for entrepreneurs and investors; Managing Director of Vator Health Fund; Co-Founder of Invent Health; Author and award-winning journalist.
All author postsThe biggest focus areas for AI investing are healthcare and biotech
Read more...It will complete and submit forms, and integrate with state benefit systems
Read more...The bill would require a report on how these industries use AI to valuate homes and underwrite loans
Read more...Startup/Business
Joined Vator on
BlueCava provides advanced technology that enables businesses to uniquely identify and profile the devices used by their customers to increase online advertising effectiveness, reduce fraud risk, and improve customer satisfaction.
With BlueCava’s patented technology, companies can uniquely identify Internet connected devices including computers, mobile phones, set top boxes and gaming consoles, to better adapt and respond to customer needs.
Joined Vator on